10-K/A

REXAHN PHARMACEUTICALS, INC FORM 10-K/A 12-31-2010

Company: Opus Genetics, Inc.
Filed: March 23, 2011
Period of Report: December 31, 2010
Accession Number: 0001140361-11-018319

View Document ↗ View on SEC.gov ↗